CHARLENE SANDERS: Open Payments
NPI 1417689324 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 7 companies in 2025. Trend: 2023 $1,584 · 2024 $1,448 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $123 |
| Alnylam Pharmaceuticals Inc. | 3 | $53 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| HEARTFLOW, INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Wegovy, ONPATTRO, Ozempic, VERQUVO, LEQVIO, BodyGuardian, FFRct, CAMZYOS.
Industry payments across KY — which companies pay providers there.
